相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibodies to watch in 2014
Janice M. Reichert
MABS (2014)
Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics
Abhishek Mathur et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties
Thomas Tiller et al.
MABS (2013)
Which are the antibodies to watch in 2013?
Janice M. Reichert
MABS (2013)
Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilities
Susan H. Tam et al.
MABS (2013)
Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics
Daniela Bumbaca et al.
AAPS JOURNAL (2012)
Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Robust recombinant FcRn production in mammalian cells enabling oriented immobilization for IgG binding studies
Giovanni Magistrelli et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
A strategy for risk mitigation of antibodies with fast clearance
Isidro Hoetzel et al.
MABS (2012)
FcRn Affinity-Pharmacokinetic Relationship of Five Human IgG4 Antibodies Engineered for Improved In Vitro FcRn Binding Properties in Cynomolgus Monkeys
Amita Datta-Mannan et al.
DRUG METABOLISM AND DISPOSITION (2012)
Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences
Weirong Wang et al.
DRUG METABOLISM AND DISPOSITION (2011)
Identification of IgG1 variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: Comparison of soluble receptor-based and cell-based binding assays
Yanmei Lu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
Weirong Wang et al.
MOLECULAR IMMUNOLOGY (2011)
Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies
Imre Kacskovics et al.
MABS (2011)
Neonatal Fc receptor and IgG-based therapeutics
Timothy T. Kuo et al.
MABS (2011)
Engineering the variable region of therapeutic IgG antibodies
Tomoyuki Igawa et al.
MABS (2011)
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
Nigel M. Stapleton et al.
NATURE COMMUNICATIONS (2011)
Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
Rong Deng et al.
DRUG METABOLISM AND DISPOSITION (2010)
Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
Takuo Suzuki et al.
JOURNAL OF IMMUNOLOGY (2010)
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
Tomoyuki Igawa et al.
NATURE BIOTECHNOLOGY (2010)
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky et al.
NATURE BIOTECHNOLOGY (2010)
Reduced elimination of IgG antibodies by engineering the variable region
T. Igawa et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
Mona Gandhi et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)
Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
Yik Andy Yeung et al.
JOURNAL OF IMMUNOLOGY (2009)
Impact of methionine oxidation on the binding of human IgG1 to FcRn and Fcγ receptors
Andrea Bertolotti-Ciarlet et al.
MOLECULAR IMMUNOLOGY (2009)
Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet
Yasmina Abdiche et al.
ANALYTICAL BIOCHEMISTRY (2008)
Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation
Dingjiang Liu et al.
BIOCHEMISTRY (2008)
A novel solid phase technology for high-throughput gene synthesis
Jan Van den Brulle et al.
BIOTECHNIQUES (2008)
Molecular engineering and design of therapeutic antibodies
Leonard G. Presta
CURRENT OPINION IN IMMUNOLOGY (2008)
A strategy for bacterial production of a soluble functional human neonatal Fc receptor
Jan Terje Andersen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies
Christine Rothe et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Monoclonal antibody clearance -: Impact of modulating the interaction of IgG with the neonatal Fc receptor
Amita Datta-Mannan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Humanized IgG(1) variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates
Amita Datta-Mannan et al.
DRUG METABOLISM AND DISPOSITION (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies
Carlos Vaccaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin
Jan Terje Andersen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Perspective - FcRn transports albumin: relevance to immunology and medicine
Clark L. Anderson et al.
TRENDS IN IMMUNOLOGY (2006)
Development of new models for the analysis of Fc-FcRn interactions
BM Gurbaxani et al.
MOLECULAR IMMUNOLOGY (2006)
Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces
JH Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
An engineered human IgG1 antibody with longer serum half-life
PR Hinton et al.
JOURNAL OF IMMUNOLOGY (2006)
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
C Vaccaro et al.
NATURE BIOTECHNOLOGY (2005)
Conferring the binding properties of the mouse MHC class I-related receptor, FcRn, onto the human ortholog by sequential rounds of site-directed mutagenesis
JC Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Biophysical properties of human antibody variable domains
S Ewert et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Increasing the affinity of a human IgG1, for the neonatal Fc receptor: Biological consequences
WF Dall'Acqua et al.
JOURNAL OF IMMUNOLOGY (2002)
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies
RJ Ober et al.
INTERNATIONAL IMMUNOLOGY (2001)
Crystal structure at 2.8 Å of an FcRn/heterodimeric Fc complex:: Mechanism of pH-dependent binding
WL Martin et al.
MOLECULAR CELL (2001)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds
J Schuurman et al.
MOLECULAR IMMUNOLOGY (2001)
Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor
AP West et al.
BIOCHEMISTRY (2000)
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides
A Knappik et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
分享论文
